Drug intelligence / Profile preview

autologous three-cellular cultured skin substitutes

Development stage
Unknown
Lead developer
Sapienza University of Rome
Modality
Cell Therapies
Administration
Topical
01

Overview

Autologous three-cellular cultured skin substitutes (CSS) are a tissue-engineered regenerative medicine product designed for the permanent closure of extensive full-thickness skin wounds. This complex skin substitute is composed of three primary autologous cell types: keratinocytes, melanocytes, and fibroblasts, which are derived from a patient's own skin biopsy. The cells are organized onto a scaffold of esterified hyaluronic acid, where fibroblasts form a dermal-like basement and keratinocytes and melanocytes (in a 1:20 ratio) form a pluristratified epithelial surface. Following surgical application, the hyaluronic acid scaffold is gradually resorbed and replaced by the host's connective tissue, while the transplanted cells integrate to restore both the structural integrity and pigmentation of the skin. This therapy has been investigated as a surgical alternative for treating severe burns, chronic ulcers, and giant congenital nevi.

Other names
autologous 3-cellular cultured skin substitutesautologous3-cellular cultured skin substitutesautologous-3-cellular cultured skin substitutesautologous three-cellular CSS

Beyond the preview

Go deeper on autologous three-cellular cultured skin substitutes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous three-cellular cultured skin substitutes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call